BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 32827429)

  • 1. A novel risk stratification model based on tumor size and multifocality to predict recurrence in pediatric PTC: comparison with adult PTC.
    Du R; Zhang Y; Kou J; Li J; Sui C; Zhang D; Fu Y; Zhou L; Fu Q; Li F; Dionigi G; Liang N; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1298036. PubMed ID: 38274235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane.
    Gulwani D; Upadhyay P; Goel R; Sarangthem V; Debraj Singh T
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):375-387. PubMed ID: 36853284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations.
    Dudhal S; Mekzine L; Prudhon B; Soocheta K; Cadot B; Mamchaoui K; Trochet D; Bitoun M
    Mol Ther Nucleic Acids; 2022 Sep; 29():733-748. PubMed ID: 36090755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target.
    Trochet D; Bitoun M
    J Exp Clin Cancer Res; 2021 Jul; 40(1):238. PubMed ID: 34294140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer.
    Ren N; Tian Z; Sun H; Lu X
    Med Sci Monit; 2020 Aug; 26():e924590. PubMed ID: 32827429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
    Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma.
    Qian Y; Pan Z; Guo Z; Ge X; Zheng G; Cao J; Huang P; Zhu X; Zhu X; Wen Q; Ge M
    Biomed Res Int; 2019; 2019():1791065. PubMed ID: 31828091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
    Jia M; Guo Y; Lu X
    Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
    Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
    Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.
    Dong W; Horiuchi K; Tokumitsu H; Sakamoto A; Noguchi E; Ueda Y; Okamoto T
    Thyroid; 2019 Jun; 29(6):802-808. PubMed ID: 30931815
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine.
    Matrone A; Campopiano MC; Nervo A; Sapuppo G; Tavarelli M; De Leo S
    Front Endocrinol (Lausanne); 2019; 10():884. PubMed ID: 31998228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.
    Lee YG; Nam Y; Shin KJ; Yoon S; Park WS; Joung JY; Seo JK; Jang J; Lee S; Nam D; Caino MC; Suh PG; Chan Chae Y
    Cancer Lett; 2020 Feb; 471():72-87. PubMed ID: 31838085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.
    Yu L; Xiao Z; Tu H; Tong B; Chen S
    Medicine (Baltimore); 2019 Nov; 98(48):e18228. PubMed ID: 31770286
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.